In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|
| Other Income | — | — | 85.3 | |
| Revenue Detail — as filed | ||||
| + Operating Income | — | — | 26,625.3 | |
| + Income from Investments (net) | — | — | 3,462.5 | |
| Expense Detail — as filed | ||||
| + Employee Remuneration & Welfare | — | — | 1,723.6 | |
| + Commission (net) | — | — | 4,793.6 | |
| + Commission & Brokerage (net) | — | — | 4,793.6 | |
| + Provision — Diminution in Investments | — | — | 175.1 | |
| + Provision — Doubtful Debts & Write-offs | — | — | 3,924.7 | |
| + Non-operating Expense | — | — | 58.6 | |
| + Non-operating Provision — Diminution in Investments | — | — | -18.8 | |
| + Non-operating Provision — Doubtful Debts | — | — | 1.6 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | ||||
| Profit before Extraordinary Items | — | — | 3,200.9 | |
| Profit / (Loss) before Tax — alt tag | — | — | 3,200.9 | |
| + Provision for Tax | — | — | 772.9 | |
| Profit / (Loss) after Tax | — | — | 2,428.0 | |
| Profit Carried to Balance Sheet | — | — | 34,066.3 | |
| Per Share — as-filed variants | ||||
| Basic & Diluted EPS before Extraordinary (not annualised) | — | — | 48.79 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | — | — | 48.79 | |
| Appropriations & Transfers | ||||
| + Transfer to Profit & Loss Account | — | — | 2,103.4 | |
| Reserves & Surplus excl. Revaluation Reserve | — | — | 63,722.7 | |
| + Interim Dividend | — | — | 0.1 | |
| + Final Dividend | — | — | 0.1 | |
| Insurance — Revenue Account (Policyholders') | ||||
| Premium Earned | — | — | 23,077.5 | |
| + Gross Premiums Written | — | — | 31,425.8 | |
| + Net Premium Written | — | — | 24,367.7 | |
| + Operating Expenses — Insurance Business | — | — | 3,105.4 | |
| + Non-operating Expenses — Non-insurance | — | — | 75.9 | |
| + Claims Paid | — | — | 14,142.3 | |
| + Incurred Claims | — | — | 16,622.9 | |
| + Change in Outstanding Claims | — | — | 2,480.6 | |
| Insurance — Shareholders' Account | ||||
| + Income — Shareholders' Account | — | — | 3,259.6 | |
| + Shareholders' Investment Income | — | — | 1,147.1 | |
| + Transfer from Policyholders' Fund | — | — | 2,103.4 | |
| With Unrealised Gains | — | — | 0.0 | |
| Without Unrealised Gains | — | — | 0.1 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | ||||
| Solvency Ratio | — | — | 0.11 | |
| Combined Ratio | — | — | 4.18 | |
| Incurred Claim Ratio | — | — | 2.88 | |
| Net Retention Ratio | — | — | 3.10 | |
| Expenses of Management Ratio | — | — | 1.28 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||
| Investor Complaints — Received | — | — | 2.00 | |
| Investor Complaints — Disposed | — | — | 2.00 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||
| Operating Expenses | — | — | 24,521.9 | |
| Other Operating Expenses | — | — | 1,381.8 | |